共 74 条
[1]
Grimwade D(1998)The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties Blood 92 2322-2333
[2]
Walker H(2001)Molecular genetics of acute myeloid leukaemia Best Pract Res Clin Haematol 14 49-64
[3]
Oliver F(2003)FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance Blood 102 2387-2394
[4]
Wheatley K(2007)The incidence and clinical significance of nucleophosmin mutations in childhood AML Blood 110 979-985
[5]
Harrison C(2005)Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia Leukemia 19 1536-1542
[6]
Harrison G(2009)Prevalence and prognostic implications of CEBPA mutations in pediatric AML: a report from the Children's Oncology Group Blood 113 6558-6566
[7]
Dash A(2008)Wilms'mor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study J Clin Oncol 26 4595-4602
[8]
Gilliland DG(2008)Mutation of the Wilms'mor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: the United Kingdom Medical Research Council Adult Leukaemia Working Party J Clin Oncol 26 5429-5435
[9]
Zwaan CM(2009)Clinical relevance of Wilms'mor 1 gene mutations in childhood acute myeloid leukemia Blood 113 5951-5960
[10]
Meshinchi S(2002)Favorable prognostic significance of CEBPA mutations in patients with Blood 100 2717-2723